Archives: Press Releases
Modulus Discovery Announces Signing of a Collaboration Agreement with the University Of Tokyo to Pursue Drug Discovery for COVID-19 and Related Emerging Virus Infections
News -
02 October, 2020 -
Modulus Discovery, Inc., a preclinical-stage technology-driven drug discovery company announced today the initiation of a research collaboration with Professor Tsutomu Suzuki of Department of Chemistry and Biotechnology, Graduate School of Engineering, University of Tokyo to pursue drug discovery on a novel target for COVID-19 and related emerging virus infections. Emerging viruses are now becoming one ...continuedModulus Discovery Receives “Mizuho Innovation Award”
News -
28 July, 2020 -
We are pleased to announce that Modulus Discovery, Inc. has been awarded the Mizuho Innovation Award which recognizes the top innovative companies in Japan. We hope to work together with Mizuho Bank and capitalize on its broad industry ties to accelerate our search for much needed new medicines through our globally networked research model and ...continuedModulus Discovery Closes $25.5M USD Series B
News -
13 May, 2020 -
Tokyo, Japan – May 13, 2020 – Modulus Discovery, Inc., a preclinical-stage technology-driven drug discovery firm, announces the successful closing of its series B funding round in the amount of 2.71 B JPY (approximately $25.5M USD). Series B investors include SBI Investments Co., Ltd., Mizuho Capital Co., Ltd., JAFCO Co., Ltd., Keio Innovation Initiative, Inc., ...continuedModulus Discovery Announces Signing of Research Data Transfer Agreement with Astellas Pharma Inc.
News -
30 May, 2019 -
Modulus Discovery, Inc. (CEO: S. Roy Kimura, Ph.D., “Modulus”), an early stage global biopharmaceutical company, announced today the signing of research data transfer agreement on a specific drug target with Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”). Under the terms of the agreement, Modulus plans to design, evaluate and optimize ...continuedModulus Discovery Announces Signing of Collaboration Agreement with Tokyo Institute of Technology
News -
09 May, 2019 -
Modulus Discovery, Inc., an early stage global biopharmaceutical company, announced today the signing of a research collaboration agreement with Professor Masahito Oue, Assistant Professor of Tokyo Institute of Technology (“Tokyo Tech”). The collaboration will focus on the implementation and scale-up of Modulus’ cutting-edge TSUBAME 3.0 is recognized as one of the world’s most efficient supercomputers, ...continuedModulus Discovery Announces Senior Appointments including Jon Mason as Scientific Advisor
News -
28 January, 2019 -
Modulus Discovery, Inc., an early stage global biopharmaceutical company, announced today the appointment of Jonathan Mason, Ph.D. as Scientific Advisor to the Company, and William Sinko, Ph.D., as Principal Scientist, Computational Drug Discovery. Dr. Mason is a global leader and scientific expert in drug discovery, particularly in the development and application of computational technologies for ...continuedModulus Discovery Announces the Initiation of a Research Collaboration with Prof. Tsutomu Suzuki, University of Tokyo
News -
31 October, 2018 -
Modulus Discovery, Inc., an early stage drug discovery company announced today the initiation of a research collaboration with Professor Tsutomu Suzuki of Department of Chemistry and Biotechnology, Graduate School of Engineering, University of Tokyo for target validation of a potential drug discovery target. Prof. Suzuki is one of the leading scientists in the field of ...continuedModulus Discovery Announces Signing of a Multi-Target Research Collaboration with Professor Osamu Nureki, University of Tokyo
News -
04 September, 2018 -
Modulus Discovery, Inc., an early stage drug discovery company announced today the signing of a multi-target research collaboration with Professor Osamu Nureki of Department of Biological Sciences, Graduate School of Science, University of Tokyo for structural analysis on several drug target proteins. Professor Nureki is a renowned structural biologist recently awarded the Purple Ribbon* from ...continuedModulus Raises 800M Japanese Yen for Its Series A Funding Round
News -
09 August, 2018 -
09 August, 2018 – Modulus Discovery, Inc., an early stage drug discovery company announced today that it has successfully raised a total of 800M Japanese Yen (approximately US $7.2M) for its series A round, led by Fast Track Initiative, Inc. (FTI) and joined by PeptiDream, Inc. (PeptiDream) and DBJ Capital Co., Ltd. (DBJ-C), the venture ...continuedModulus Announces the Appointment of Former Senior Pharma Executive, Professor Wataru Uchida, as Scientific Advisor
News -
31 July, 2018 -
Modulus Discovery, Inc., an early stage drug discovery company announced today the appointment of Wataru Uchida, Professor at the Center for Drug Discovery and Exploratory Clinical Trials, Tohoku University, as Scientific Advisor. Professor Uchida served as Head of Drug Discovery Research, Senior Corporate Executive at Astellas Pharma Inc. until March 2018, and has more than ...continued